Intracellular Ca2+ Modulators EconoKit
|
|
|
|
|
Intracellular Ca2+ Á¶Àý¿¡ °ü¿©ÇÏ´Â 24Á¾ÀÇ compound ¸ðÀ½ ŶƮÀÔ´Ï´Ù. |
|
| Alomone labs |

±¸¼ºÇ°
| Product |
Cat. No. |
Size |
Purity |
MW |
Solubility |
Specific Activity and Recommended Concentration |
| (¡¾)-Bay K 8644 |
B-350 |
2 x 1 mg |
>99% |
356% |
DMSO, Ethanol |
L-type, voltage-gated Ca2+ channel agonist: 1-5uM |
| A23187 |
A-600 |
2 x 5 mg |
>98% |
523.6 |
DMSO |
Calcium ionophore (positive control): 1-10uM |
| Anhydroryanodine |
A-510 |
50 ug |
>98% |
475.5 |
Methanol |
Nonactive analogue of Ryanodine (Negative control): 100uM-1mM |
| BAPTA-AM |
- |
2 mg |
>90% |
764.7 |
DMSO |
Ca2+ chelator (negative control): 10-50uM |
| Caffeine |
- |
500 mg |
>99% |
194.2 |
Water |
RYR activator: 100nM-10uM |
| Cyclic ADP-ribose |
- |
- |
>90% |
541.3 |
Water |
RYR agonist: 10nM -10uM |
| Cyclopiazonic Acid |
C-750 |
2 x 5 mg |
>98% |
336.4 |
DMSO |
SERCA pump inhibitor: 1-10uM |
| D-IP3 |
- |
0.1 mg |
>99% |
648.6 |
Water |
IP3 Receptor agonist (active analogue): 10-100uM |
| Dantrolene |
- |
5 mg |
>99% |
337.2 |
DMF, Methanol |
RYR antagonist: 10-100uM |
| Imperatoxin A |
I-300 |
5ug |
>99% |
3758 |
Water |
RYR activator: 10-300nM |
| Ionomycin |
I-700 |
1 mg |
>98% |
747% |
DMSO |
Ca2+ Ionophore: 0.1-2uM |
| L-IP3 |
- |
0.1 mg |
>90% |
648.6 |
Water |
Nonactive analogue (Negative control): 100uM |
| Loperamide |
- |
50 mg |
>99% |
513.5 |
DMSO |
CRAC activator: 10-30uM |
| rMaurocalcine |
RTM-100 |
2 x 10 ug |
>98% |
3864 |
Water |
RYR modulator. RYR1: 50-500nM, RYR2: 200 nM-2uM |
| Miconazole |
- |
50 mg |
>95% |
479% |
DMSO |
CRAC inhibitor: 50uM |
| Neomycin sulfate |
- |
50 mg |
>85% |
908.9 |
- |
PLC inhibitor: 1-10uM |
| Ochratoxin A |
O-400 |
0.5 mg |
>98% |
403.8 |
DMSO, Methanol |
Causes an increase in endoplasmic reticulum ATP-dependent calcium pump activities: 100nM-1uM |
| Paxilline |
P-450 |
0.45 mg |
>98% |
435.6 |
DMSO, Methanol, Acetone |
SERCA pump inhibitor: 1-20uM |
| Ruthenium Red |
- |
5 mg |
>97% |
786.4 |
Water |
RYR antagonist: 1-10uM |
| Ryanodine |
R-500 |
2 x 1 mg |
>98% |
493.5 |
Methanol |
Agonist of RYR (induces the release of intracellular Ca2+): 1-25uM |
| t-BuBHQ |
T-220 |
250 mg |
>97% |
222.3 |
Ethanol, Methanol |
SERCA pump inhibitor: 1-20uM |
| Thapsigargin |
T-650 |
2 x 0.65 mg |
>99% |
650.7 |
DMSO, Ethanol |
SERCA pump inhibitor: 50nM-1uM |
| Thapsigargin epoxide |
T-670 |
50ug |
>99% |
632.7 |
DMSO, Ethanol |
Nonactive analogue of Thapsigargin (Negative control): 100nM |
| TMB-8 |
- |
5 mg |
>97% |
432 |
Water |
SERCA pump inhibitor: 1-100uM |